Ligand validation:4H2V

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4H2V designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4H2V_AMP_A_402	89%	59%	0.1	0.978	0.71	0.87	-	1	0	0	100%	1
4H2V_AMP_B_402	89%	60%	0.102	0.98	0.77	0.76	-	1	0	0	100%	1
3MF2_AMP_A_1010	80%	30%	0.111	0.959	1.59	1.19	3	3	0	0	100%	1
4H2S_AMP_A_1001	78%	61%	0.121	0.965	0.64	0.86	-	1	1	0	100%	0.84
4H2W_AMP_B_402	71%	60%	0.123	0.945	0.66	0.86	-	1	2	0	100%	0.82
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
3CLR_AMP_C_1262	100%	41%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1
5NRH_AMP_B_700	99%	34%	0.051	0.989	1.23	1.39	3	2	0	0	100%	1
4M0K_AMP_D_300	99%	40%	0.047	0.983	0.89	1.43	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.